Page last updated: 2024-08-16
sb 202190 and allose
sb 202190 has been researched along with allose in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Baker, AF; Carbajal, L; Gill, A; Hanke, NT; Malm, SW | 1 |
Other Studies
1 other study(ies) available for sb 202190 and allose
| Article | Year |
|---|---|
The anti-tumor efficacy of 2-deoxyglucose and D-allose are enhanced with p38 inhibition in pancreatic and ovarian cell lines.
Topics: Antineoplastic Agents; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Dose-Response Relationship, Drug; Female; Genes, Reporter; Glucose; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; Lactic Acid; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Pancreatic Neoplasms; Poly(ADP-ribose) Polymerases; Pyridines; Transcription, Genetic | 2015 |